Helping people in India quit tobacco through brief advice in clinics
Adapting and evaluating a brief advice tobacco intervention in high-reach, low-resource settings in India
This study is testing a new way to help people in India quit using tobacco by training local health workers to give quick advice and support, using tools like an app and social media to make it easier for everyone to get the help they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10833125 on NIH RePORTER |
What this research studies
This research aims to adapt and evaluate a brief advice intervention to help individuals in India quit using tobacco. The approach involves training less credentialed health workers in dental and tuberculosis clinics, as well as non-governmental health centers, to provide quick counseling and referrals for cessation services. By utilizing technology, such as an app and social media, the project seeks to enhance the support these workers can offer. The goal is to create a culturally relevant and accessible program that meets the needs of the Indian population.
Who could benefit from this research
Good fit: Ideal candidates for this research are tobacco users in India seeking assistance to quit smoking or using smokeless tobacco.
Not a fit: Patients who are not tobacco users or those who have access to high-resource cessation programs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase tobacco cessation rates among millions of users in India, leading to improved health outcomes.
How similar studies have performed: Previous research has shown that brief advice interventions can be effective in promoting tobacco cessation, although this specific adaptation for low-resource settings is novel.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Viswanath, Kasisomayajula — Dana-Farber Cancer Inst
- Study coordinator: Viswanath, Kasisomayajula
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.